nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—NR3C1—urine—urinary bladder cancer	0.0155	0.191	CbGeAlD
Flunisolide—CYP3A4—urine—urinary bladder cancer	0.0117	0.144	CbGeAlD
Flunisolide—SERPINA6—renal system—urinary bladder cancer	0.00864	0.106	CbGeAlD
Flunisolide—SERPINA6—female reproductive system—urinary bladder cancer	0.00692	0.0853	CbGeAlD
Flunisolide—NR3C1—prostate gland—urinary bladder cancer	0.00555	0.0684	CbGeAlD
Flunisolide—NR3C1—seminal vesicle—urinary bladder cancer	0.0047	0.0579	CbGeAlD
Flunisolide—NR3C1—epithelium—urinary bladder cancer	0.00408	0.0503	CbGeAlD
Flunisolide—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00393	0.0484	CbGeAlD
Flunisolide—NR3C1—renal system—urinary bladder cancer	0.00378	0.0466	CbGeAlD
Flunisolide—NR3C1—urethra—urinary bladder cancer	0.00372	0.0458	CbGeAlD
Flunisolide—NR3C1—female reproductive system—urinary bladder cancer	0.00303	0.0373	CbGeAlD
Flunisolide—CYP3A4—renal system—urinary bladder cancer	0.00286	0.0353	CbGeAlD
Flunisolide—NR3C1—vagina—urinary bladder cancer	0.00274	0.0338	CbGeAlD
Flunisolide—CYP3A4—female reproductive system—urinary bladder cancer	0.00229	0.0282	CbGeAlD
Flunisolide—NR3C1—lymph node—urinary bladder cancer	0.00177	0.0218	CbGeAlD
Flunisolide—NR3C1—Endoderm Differentiation—BPTF—urinary bladder cancer	0.00167	0.0714	CbGpPWpGaD
Flunisolide—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.0016	0.0688	CbGpPWpGaD
Flunisolide—Insomnia—Fluorouracil—urinary bladder cancer	0.00138	0.00154	CcSEcCtD
Flunisolide—Migraine—Doxorubicin—urinary bladder cancer	0.00138	0.00154	CcSEcCtD
Flunisolide—Discomfort—Etoposide—urinary bladder cancer	0.00137	0.00153	CcSEcCtD
Flunisolide—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00136	0.00152	CcSEcCtD
Flunisolide—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00136	0.00152	CcSEcCtD
Flunisolide—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.00135	0.00151	CcSEcCtD
Flunisolide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00135	0.00151	CcSEcCtD
Flunisolide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00134	0.0015	CcSEcCtD
Flunisolide—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00134	0.0015	CcSEcCtD
Flunisolide—Fatigue—Gemcitabine—urinary bladder cancer	0.00134	0.0015	CcSEcCtD
Flunisolide—Constipation—Gemcitabine—urinary bladder cancer	0.00133	0.00148	CcSEcCtD
Flunisolide—Pain—Gemcitabine—urinary bladder cancer	0.00133	0.00148	CcSEcCtD
Flunisolide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00133	0.00148	CcSEcCtD
Flunisolide—Asthenia—Thiotepa—urinary bladder cancer	0.00132	0.00148	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00132	0.00147	CcSEcCtD
Flunisolide—Infection—Etoposide—urinary bladder cancer	0.00132	0.00147	CcSEcCtD
Flunisolide—Abdominal distension—Epirubicin—urinary bladder cancer	0.00132	0.00147	CcSEcCtD
Flunisolide—Pruritus—Thiotepa—urinary bladder cancer	0.00131	0.00146	CcSEcCtD
Flunisolide—Pain—Fluorouracil—urinary bladder cancer	0.00131	0.00146	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.0013	0.00145	CcSEcCtD
Flunisolide—Tachycardia—Etoposide—urinary bladder cancer	0.00129	0.00145	CcSEcCtD
Flunisolide—Dyspnoea—Cisplatin—urinary bladder cancer	0.00129	0.00144	CcSEcCtD
Flunisolide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00128	0.00143	CcSEcCtD
Flunisolide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00128	0.00143	CcSEcCtD
Flunisolide—Diarrhoea—Thiotepa—urinary bladder cancer	0.00126	0.00141	CcSEcCtD
Flunisolide—Decreased appetite—Cisplatin—urinary bladder cancer	0.00126	0.00141	CcSEcCtD
Flunisolide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00126	0.00141	CcSEcCtD
Flunisolide—Bronchitis—Epirubicin—urinary bladder cancer	0.00126	0.0014	CcSEcCtD
Flunisolide—Pneumonia—Methotrexate—urinary bladder cancer	0.00125	0.0014	CcSEcCtD
Flunisolide—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.00125	0.0014	CcSEcCtD
Flunisolide—Pain—Cisplatin—urinary bladder cancer	0.00124	0.00138	CcSEcCtD
Flunisolide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00123	0.00137	CcSEcCtD
Flunisolide—Dizziness—Thiotepa—urinary bladder cancer	0.00122	0.00136	CcSEcCtD
Flunisolide—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00122	0.00136	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.00122	0.00136	CcSEcCtD
Flunisolide—Stomatitis—Methotrexate—urinary bladder cancer	0.00121	0.00136	CcSEcCtD
Flunisolide—Urticaria—Fluorouracil—urinary bladder cancer	0.00121	0.00135	CcSEcCtD
Flunisolide—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00121	0.00135	CcSEcCtD
Flunisolide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00121	0.00135	CcSEcCtD
Flunisolide—Sweating—Methotrexate—urinary bladder cancer	0.00119	0.00133	CcSEcCtD
Flunisolide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00119	0.00133	CcSEcCtD
Flunisolide—Weight increased—Epirubicin—urinary bladder cancer	0.00119	0.00133	CcSEcCtD
Flunisolide—Dyspnoea—Etoposide—urinary bladder cancer	0.00118	0.00132	CcSEcCtD
Flunisolide—Epistaxis—Methotrexate—urinary bladder cancer	0.00118	0.00131	CcSEcCtD
Flunisolide—Vomiting—Thiotepa—urinary bladder cancer	0.00117	0.00131	CcSEcCtD
Flunisolide—Pneumonia—Epirubicin—urinary bladder cancer	0.00117	0.00131	CcSEcCtD
Flunisolide—Rash—Thiotepa—urinary bladder cancer	0.00116	0.0013	CcSEcCtD
Flunisolide—Bronchitis—Doxorubicin—urinary bladder cancer	0.00116	0.0013	CcSEcCtD
Flunisolide—Dermatitis—Thiotepa—urinary bladder cancer	0.00116	0.0013	CcSEcCtD
Flunisolide—Headache—Thiotepa—urinary bladder cancer	0.00116	0.00129	CcSEcCtD
Flunisolide—Decreased appetite—Etoposide—urinary bladder cancer	0.00115	0.00129	CcSEcCtD
Flunisolide—Body temperature increased—Cisplatin—urinary bladder cancer	0.00114	0.00128	CcSEcCtD
Flunisolide—Fatigue—Etoposide—urinary bladder cancer	0.00114	0.00128	CcSEcCtD
Flunisolide—Stomatitis—Epirubicin—urinary bladder cancer	0.00114	0.00127	CcSEcCtD
Flunisolide—Constipation—Etoposide—urinary bladder cancer	0.00113	0.00127	CcSEcCtD
Flunisolide—Pain—Etoposide—urinary bladder cancer	0.00113	0.00127	CcSEcCtD
Flunisolide—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00113	0.00127	CcSEcCtD
Flunisolide—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00113	0.00127	CcSEcCtD
Flunisolide—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00113	0.00126	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00112	0.00126	CcSEcCtD
Flunisolide—Sweating—Epirubicin—urinary bladder cancer	0.00112	0.00125	CcSEcCtD
Flunisolide—Asthenia—Gemcitabine—urinary bladder cancer	0.00111	0.00124	CcSEcCtD
Flunisolide—Pharyngitis—Methotrexate—urinary bladder cancer	0.00111	0.00124	CcSEcCtD
Flunisolide—NR3C1—Signaling events mediated by HDAC Class II—HDAC4—urinary bladder cancer	0.0011	0.0472	CbGpPWpGaD
Flunisolide—Weight increased—Doxorubicin—urinary bladder cancer	0.0011	0.00123	CcSEcCtD
Flunisolide—Epistaxis—Epirubicin—urinary bladder cancer	0.0011	0.00123	CcSEcCtD
Flunisolide—Pruritus—Gemcitabine—urinary bladder cancer	0.0011	0.00123	CcSEcCtD
Flunisolide—Nausea—Thiotepa—urinary bladder cancer	0.0011	0.00122	CcSEcCtD
Flunisolide—Sinusitis—Epirubicin—urinary bladder cancer	0.00109	0.00122	CcSEcCtD
Flunisolide—Feeling abnormal—Etoposide—urinary bladder cancer	0.00109	0.00122	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—urinary bladder cancer	0.00109	0.00121	CcSEcCtD
Flunisolide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00108	0.00121	CcSEcCtD
Flunisolide—Pruritus—Fluorouracil—urinary bladder cancer	0.00108	0.00121	CcSEcCtD
Flunisolide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00107	0.00119	CcSEcCtD
Flunisolide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00106	0.00119	CcSEcCtD
Flunisolide—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00106	0.00118	CcSEcCtD
Flunisolide—Urticaria—Etoposide—urinary bladder cancer	0.00105	0.00118	CcSEcCtD
Flunisolide—Stomatitis—Doxorubicin—urinary bladder cancer	0.00105	0.00117	CcSEcCtD
Flunisolide—Rhinitis—Epirubicin—urinary bladder cancer	0.00105	0.00117	CcSEcCtD
Flunisolide—Abdominal pain—Etoposide—urinary bladder cancer	0.00105	0.00117	CcSEcCtD
Flunisolide—Body temperature increased—Etoposide—urinary bladder cancer	0.00105	0.00117	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00105	0.00117	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00105	0.00117	CcSEcCtD
Flunisolide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00105	0.00117	CcSEcCtD
Flunisolide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00104	0.00116	CcSEcCtD
Flunisolide—Asthenia—Cisplatin—urinary bladder cancer	0.00104	0.00116	CcSEcCtD
Flunisolide—Pharyngitis—Epirubicin—urinary bladder cancer	0.00104	0.00116	CcSEcCtD
Flunisolide—Sweating—Doxorubicin—urinary bladder cancer	0.00103	0.00115	CcSEcCtD
Flunisolide—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00103	0.00115	CcSEcCtD
Flunisolide—Epistaxis—Doxorubicin—urinary bladder cancer	0.00102	0.00114	CcSEcCtD
Flunisolide—Sinusitis—Doxorubicin—urinary bladder cancer	0.00101	0.00113	CcSEcCtD
Flunisolide—Dizziness—Fluorouracil—urinary bladder cancer	0.00101	0.00113	CcSEcCtD
Flunisolide—Chills—Methotrexate—urinary bladder cancer	0.001	0.00112	CcSEcCtD
Flunisolide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000991	0.00111	CcSEcCtD
Flunisolide—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00099	0.00111	CcSEcCtD
Flunisolide—Vomiting—Gemcitabine—urinary bladder cancer	0.000988	0.0011	CcSEcCtD
Flunisolide—Rash—Gemcitabine—urinary bladder cancer	0.000979	0.00109	CcSEcCtD
Flunisolide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000979	0.00109	CcSEcCtD
Flunisolide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000977	0.00109	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—urinary bladder cancer	0.000974	0.00109	CcSEcCtD
Flunisolide—Headache—Gemcitabine—urinary bladder cancer	0.000973	0.00109	CcSEcCtD
Flunisolide—Vomiting—Fluorouracil—urinary bladder cancer	0.000971	0.00108	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—urinary bladder cancer	0.000971	0.00108	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000964	0.00108	CcSEcCtD
Flunisolide—Rash—Fluorouracil—urinary bladder cancer	0.000963	0.00108	CcSEcCtD
Flunisolide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000962	0.00107	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000961	0.00107	CcSEcCtD
Flunisolide—Headache—Fluorouracil—urinary bladder cancer	0.000957	0.00107	CcSEcCtD
Flunisolide—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000954	0.00107	CcSEcCtD
Flunisolide—Dysgeusia—Methotrexate—urinary bladder cancer	0.000953	0.00106	CcSEcCtD
Flunisolide—Asthenia—Etoposide—urinary bladder cancer	0.000952	0.00106	CcSEcCtD
Flunisolide—Back pain—Methotrexate—urinary bladder cancer	0.000942	0.00105	CcSEcCtD
Flunisolide—Chills—Epirubicin—urinary bladder cancer	0.000939	0.00105	CcSEcCtD
Flunisolide—Pruritus—Etoposide—urinary bladder cancer	0.000939	0.00105	CcSEcCtD
Flunisolide—Nausea—Gemcitabine—urinary bladder cancer	0.000923	0.00103	CcSEcCtD
Flunisolide—Vomiting—Cisplatin—urinary bladder cancer	0.000921	0.00103	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—urinary bladder cancer	0.000918	0.00102	CcSEcCtD
Flunisolide—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000916	0.00102	CcSEcCtD
Flunisolide—Rash—Cisplatin—urinary bladder cancer	0.000913	0.00102	CcSEcCtD
Flunisolide—Dermatitis—Cisplatin—urinary bladder cancer	0.000912	0.00102	CcSEcCtD
Flunisolide—Malnutrition—Epirubicin—urinary bladder cancer	0.000911	0.00102	CcSEcCtD
Flunisolide—Diarrhoea—Etoposide—urinary bladder cancer	0.000908	0.00101	CcSEcCtD
Flunisolide—Nausea—Fluorouracil—urinary bladder cancer	0.000907	0.00101	CcSEcCtD
Flunisolide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000903	0.00101	CcSEcCtD
Flunisolide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000892	0.000996	CcSEcCtD
Flunisolide—Back pain—Epirubicin—urinary bladder cancer	0.000881	0.000984	CcSEcCtD
Flunisolide—Malaise—Methotrexate—urinary bladder cancer	0.000878	0.00098	CcSEcCtD
Flunisolide—Dizziness—Etoposide—urinary bladder cancer	0.000877	0.00098	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—urinary bladder cancer	0.000875	0.000977	CcSEcCtD
Flunisolide—Chills—Doxorubicin—urinary bladder cancer	0.000869	0.00097	CcSEcCtD
Flunisolide—Nausea—Cisplatin—urinary bladder cancer	0.00086	0.00096	CcSEcCtD
Flunisolide—Vision blurred—Epirubicin—urinary bladder cancer	0.000859	0.000959	CcSEcCtD
Flunisolide—Cough—Methotrexate—urinary bladder cancer	0.00085	0.000949	CcSEcCtD
Flunisolide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000845	0.000944	CcSEcCtD
Flunisolide—Vomiting—Etoposide—urinary bladder cancer	0.000843	0.000942	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—urinary bladder cancer	0.000843	0.000941	CcSEcCtD
Flunisolide—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.000839	0.036	CbGpPWpGaD
Flunisolide—Agitation—Epirubicin—urinary bladder cancer	0.000837	0.000935	CcSEcCtD
Flunisolide—Rash—Etoposide—urinary bladder cancer	0.000836	0.000934	CcSEcCtD
Flunisolide—Dermatitis—Etoposide—urinary bladder cancer	0.000836	0.000933	CcSEcCtD
Flunisolide—Headache—Etoposide—urinary bladder cancer	0.000831	0.000928	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—urinary bladder cancer	0.000829	0.000926	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—urinary bladder cancer	0.000829	0.000926	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000826	0.000922	CcSEcCtD
Flunisolide—Malaise—Epirubicin—urinary bladder cancer	0.000822	0.000917	CcSEcCtD
Flunisolide—Discomfort—Methotrexate—urinary bladder cancer	0.000819	0.000914	CcSEcCtD
Flunisolide—Vertigo—Epirubicin—urinary bladder cancer	0.000819	0.000914	CcSEcCtD
Flunisolide—Syncope—Epirubicin—urinary bladder cancer	0.000817	0.000912	CcSEcCtD
Flunisolide—Back pain—Doxorubicin—urinary bladder cancer	0.000815	0.000911	CcSEcCtD
Flunisolide—Palpitations—Epirubicin—urinary bladder cancer	0.000805	0.000899	CcSEcCtD
Flunisolide—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000801	0.000894	CcSEcCtD
Flunisolide—Cough—Epirubicin—urinary bladder cancer	0.000795	0.000888	CcSEcCtD
Flunisolide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000794	0.000887	CcSEcCtD
Flunisolide—Infection—Methotrexate—urinary bladder cancer	0.000789	0.000881	CcSEcCtD
Flunisolide—Nausea—Etoposide—urinary bladder cancer	0.000788	0.00088	CcSEcCtD
Flunisolide—Hypertension—Epirubicin—urinary bladder cancer	0.000787	0.000878	CcSEcCtD
Flunisolide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000782	0.000873	CcSEcCtD
Flunisolide—Chest pain—Epirubicin—urinary bladder cancer	0.000776	0.000866	CcSEcCtD
Flunisolide—Myalgia—Epirubicin—urinary bladder cancer	0.000776	0.000866	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—urinary bladder cancer	0.000775	0.000865	CcSEcCtD
Flunisolide—Anxiety—Epirubicin—urinary bladder cancer	0.000773	0.000863	CcSEcCtD
Flunisolide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000768	0.000858	CcSEcCtD
Flunisolide—Discomfort—Epirubicin—urinary bladder cancer	0.000766	0.000856	CcSEcCtD
Flunisolide—Malaise—Doxorubicin—urinary bladder cancer	0.00076	0.000849	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—urinary bladder cancer	0.000757	0.000846	CcSEcCtD
Flunisolide—Syncope—Doxorubicin—urinary bladder cancer	0.000756	0.000844	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—KRT5—urinary bladder cancer	0.000753	0.0323	CbGpPWpGaD
Flunisolide—Palpitations—Doxorubicin—urinary bladder cancer	0.000745	0.000832	CcSEcCtD
Flunisolide—Oedema—Epirubicin—urinary bladder cancer	0.000744	0.00083	CcSEcCtD
Flunisolide—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000741	0.0318	CbGpPWpGaD
Flunisolide—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000741	0.000827	CcSEcCtD
Flunisolide—Infection—Epirubicin—urinary bladder cancer	0.000739	0.000825	CcSEcCtD
Flunisolide—Cough—Doxorubicin—urinary bladder cancer	0.000736	0.000821	CcSEcCtD
Flunisolide—Shock—Epirubicin—urinary bladder cancer	0.000732	0.000817	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—urinary bladder cancer	0.000728	0.000813	CcSEcCtD
Flunisolide—Tachycardia—Epirubicin—urinary bladder cancer	0.000726	0.00081	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000724	0.000808	CcSEcCtD
Flunisolide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000719	0.000803	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—urinary bladder cancer	0.000719	0.000802	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—urinary bladder cancer	0.000718	0.000801	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—urinary bladder cancer	0.000718	0.000801	CcSEcCtD
Flunisolide—Anxiety—Doxorubicin—urinary bladder cancer	0.000715	0.000799	CcSEcCtD
Flunisolide—Discomfort—Doxorubicin—urinary bladder cancer	0.000709	0.000792	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000708	0.000791	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000699	0.000781	CcSEcCtD
Flunisolide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000691	0.000771	CcSEcCtD
Flunisolide—Oedema—Doxorubicin—urinary bladder cancer	0.000688	0.000768	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—urinary bladder cancer	0.000685	0.000765	CcSEcCtD
Flunisolide—Infection—Doxorubicin—urinary bladder cancer	0.000684	0.000763	CcSEcCtD
Flunisolide—Pain—Methotrexate—urinary bladder cancer	0.000679	0.000759	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000677	0.000756	CcSEcCtD
Flunisolide—Shock—Doxorubicin—urinary bladder cancer	0.000677	0.000756	CcSEcCtD
Flunisolide—Insomnia—Epirubicin—urinary bladder cancer	0.000673	0.000751	CcSEcCtD
Flunisolide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000671	0.00075	CcSEcCtD
Flunisolide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000665	0.000743	CcSEcCtD
Flunisolide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000663	0.00074	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000655	0.000731	CcSEcCtD
Flunisolide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000655	0.000731	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00065	0.000726	CcSEcCtD
Flunisolide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000646	0.000722	CcSEcCtD
Flunisolide—Fatigue—Epirubicin—urinary bladder cancer	0.000641	0.000716	CcSEcCtD
Flunisolide—Pain—Epirubicin—urinary bladder cancer	0.000636	0.00071	CcSEcCtD
Flunisolide—Constipation—Epirubicin—urinary bladder cancer	0.000636	0.00071	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.000635	0.0272	CbGpPWpGaD
Flunisolide—Urticaria—Methotrexate—urinary bladder cancer	0.000631	0.000705	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000628	0.000701	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000628	0.000701	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000627	0.0007	CcSEcCtD
Flunisolide—Insomnia—Doxorubicin—urinary bladder cancer	0.000622	0.000695	CcSEcCtD
Flunisolide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000613	0.000685	CcSEcCtD
Flunisolide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000613	0.000684	CcSEcCtD
Flunisolide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000608	0.000679	CcSEcCtD
Flunisolide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000606	0.000676	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000601	0.0258	CbGpPWpGaD
Flunisolide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000598	0.000668	CcSEcCtD
Flunisolide—Fatigue—Doxorubicin—urinary bladder cancer	0.000593	0.000662	CcSEcCtD
Flunisolide—Urticaria—Epirubicin—urinary bladder cancer	0.000591	0.00066	CcSEcCtD
Flunisolide—Pain—Doxorubicin—urinary bladder cancer	0.000588	0.000657	CcSEcCtD
Flunisolide—Constipation—Doxorubicin—urinary bladder cancer	0.000588	0.000657	CcSEcCtD
Flunisolide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000588	0.000656	CcSEcCtD
Flunisolide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000588	0.000656	CcSEcCtD
Flunisolide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000585	0.000654	CcSEcCtD
Flunisolide—Asthenia—Methotrexate—urinary bladder cancer	0.00057	0.000637	CcSEcCtD
Flunisolide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000567	0.000633	CcSEcCtD
Flunisolide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000563	0.000628	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—urinary bladder cancer	0.000562	0.000628	CcSEcCtD
Flunisolide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000548	0.000612	CcSEcCtD
Flunisolide—Urticaria—Doxorubicin—urinary bladder cancer	0.000547	0.00061	CcSEcCtD
Flunisolide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000544	0.000607	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000544	0.000607	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000544	0.000607	CcSEcCtD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.000539	0.0231	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—ESR2—urinary bladder cancer	0.000534	0.0229	CbGpPWpGaD
Flunisolide—Asthenia—Epirubicin—urinary bladder cancer	0.000533	0.000596	CcSEcCtD
Flunisolide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000528	0.0226	CbGpPWpGaD
Flunisolide—Pruritus—Epirubicin—urinary bladder cancer	0.000526	0.000587	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—urinary bladder cancer	0.000525	0.000587	CcSEcCtD
Flunisolide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000509	0.000568	CcSEcCtD
Flunisolide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000507	0.000566	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—urinary bladder cancer	0.000505	0.000564	CcSEcCtD
Flunisolide—Rash—Methotrexate—urinary bladder cancer	0.000501	0.000559	CcSEcCtD
Flunisolide—Dermatitis—Methotrexate—urinary bladder cancer	0.000501	0.000559	CcSEcCtD
Flunisolide—Headache—Methotrexate—urinary bladder cancer	0.000498	0.000556	CcSEcCtD
Flunisolide—Asthenia—Doxorubicin—urinary bladder cancer	0.000494	0.000551	CcSEcCtD
Flunisolide—Dizziness—Epirubicin—urinary bladder cancer	0.000492	0.000549	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—urinary bladder cancer	0.000487	0.000544	CcSEcCtD
Flunisolide—Vomiting—Epirubicin—urinary bladder cancer	0.000473	0.000528	CcSEcCtD
Flunisolide—Nausea—Methotrexate—urinary bladder cancer	0.000472	0.000527	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000471	0.000526	CcSEcCtD
Flunisolide—Rash—Epirubicin—urinary bladder cancer	0.000469	0.000524	CcSEcCtD
Flunisolide—Dermatitis—Epirubicin—urinary bladder cancer	0.000468	0.000523	CcSEcCtD
Flunisolide—Headache—Epirubicin—urinary bladder cancer	0.000466	0.00052	CcSEcCtD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.000458	0.0196	CbGpPWpGaD
Flunisolide—Dizziness—Doxorubicin—urinary bladder cancer	0.000455	0.000508	CcSEcCtD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000454	0.0195	CbGpPWpGaD
Flunisolide—Nausea—Epirubicin—urinary bladder cancer	0.000442	0.000493	CcSEcCtD
Flunisolide—Vomiting—Doxorubicin—urinary bladder cancer	0.000437	0.000488	CcSEcCtD
Flunisolide—Rash—Doxorubicin—urinary bladder cancer	0.000434	0.000484	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000433	0.000484	CcSEcCtD
Flunisolide—Headache—Doxorubicin—urinary bladder cancer	0.000431	0.000481	CcSEcCtD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.000422	0.0181	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—urinary bladder cancer	0.000421	0.0181	CbGpPWpGaD
Flunisolide—Nausea—Doxorubicin—urinary bladder cancer	0.000409	0.000456	CcSEcCtD
Flunisolide—NR3C1—Nuclear Receptors—ESR1—urinary bladder cancer	0.000324	0.0139	CbGpPWpGaD
Flunisolide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—urinary bladder cancer	0.000324	0.0139	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000324	0.0139	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—NCOR1—urinary bladder cancer	0.000307	0.0132	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptors—PPARG—urinary bladder cancer	0.000295	0.0127	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—urinary bladder cancer	0.00029	0.0124	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000288	0.0124	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000284	0.0122	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.000256	0.011	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000248	0.0106	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—urinary bladder cancer	0.000243	0.0104	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000234	0.01	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.000234	0.01	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000233	0.00998	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.000225	0.00965	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.000218	0.00933	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—CREBBP—urinary bladder cancer	0.000211	0.00905	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000211	0.00905	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.000199	0.00852	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.000197	0.00847	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000178	0.00761	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.000177	0.00758	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000173	0.0074	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000159	0.00682	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000157	0.00672	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000155	0.00664	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.000154	0.00661	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.000153	0.00658	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000152	0.00654	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000151	0.00646	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000151	0.00646	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000149	0.00637	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.000148	0.00635	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.000144	0.00618	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.000144	0.00617	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000138	0.00593	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.000138	0.00592	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000138	0.00591	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000136	0.00583	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000132	0.00567	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000129	0.00552	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000125	0.00536	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000124	0.00533	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000124	0.00532	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000122	0.00525	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000122	0.00522	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000119	0.00508	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000116	0.00499	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000111	0.00475	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.00011	0.00474	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.00011	0.00471	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000107	0.00458	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.000106	0.00453	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000106	0.00452	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000105	0.00449	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000104	0.00448	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000103	0.00443	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	9.19e-05	0.00394	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	9.17e-05	0.00393	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	8.49e-05	0.00364	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	8.26e-05	0.00354	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	8.14e-05	0.00349	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	7.6e-05	0.00326	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	7.48e-05	0.00321	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	7.29e-05	0.00313	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	7.28e-05	0.00312	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	6.6e-05	0.00283	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	6.4e-05	0.00274	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	6.25e-05	0.00268	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TNF—urinary bladder cancer	5.87e-05	0.00252	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	5.63e-05	0.00241	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.07e-05	0.00217	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.44e-05	0.0019	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	4.42e-05	0.0019	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.38e-05	0.00188	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.08e-05	0.00175	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	4.03e-05	0.00173	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	4.03e-05	0.00173	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.02e-05	0.00172	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	3.87e-05	0.00166	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR2—urinary bladder cancer	3.51e-05	0.0015	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.72e-05	0.00117	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	2.71e-05	0.00116	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.58e-05	0.0011	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.58e-05	0.0011	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	2.55e-05	0.00109	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.36e-05	0.00101	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.3e-05	0.000986	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ESR1—urinary bladder cancer	2.13e-05	0.000913	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.12e-05	0.00091	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2e-05	0.000859	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.95e-05	0.000837	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PPARG—urinary bladder cancer	1.94e-05	0.000833	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	1.87e-05	0.0008	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.56e-05	0.000669	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.41e-05	0.000605	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.22e-05	0.000523	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.13e-05	0.000484	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.13e-05	0.000484	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MYC—urinary bladder cancer	1.11e-05	0.000475	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.09e-05	0.000469	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.1e-06	0.00039	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.59e-06	0.000325	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.06e-06	0.000302	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.97e-06	0.000299	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.97e-06	0.000299	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.68e-06	0.000286	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.56e-06	0.000281	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.16e-06	0.000264	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5e-06	0.000214	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.8e-06	0.000206	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.93e-06	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.43e-06	0.000147	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.27e-06	0.00014	CbGpPWpGaD
